Research Library

Life Sciences Manufacturing and Quality: The New Path to Performance

Life Sciences companies are attempting to improve compliance and manufacturing efficiency while they drive to grow revenue and margins. However, current market conditions are creating substantial headwinds to attaining these targets. Some of these headwinds originate with regulators, both because of increasingly complex global regulation and regulatory oversight, as well as recent FDA expectations that industry shift from a compliance view to an “organizational excellence” view. 

Author Name: Dan Jacob
Date: Sep 1, 2017

Get Access to Valuable Research and Insights

Search Our Research For More Information

Enter a keyword to search for a relevant article from our research library.